Prosecution Insights
Last updated: November 15, 2026
Application No. 18/578,366

LIQUID TRANSFER DEVICE WITH VALVE

Final Rejection §103
Filed
Jan 11, 2024
Priority
Jul 19, 2021 — provisional 63/223,318 +2 more
Examiner
KIDWELL, MICHELE M
Art Unit
3781
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
West Pharma Services Il Ltd.
OA Round
2 (Final)
64%
Grant Probability
Moderate
3-4
OA Rounds
83%
With Interview

Examiner Intelligence

Grants 64% of resolved cases
64%
Career Allowance Rate
764 granted / 1195 resolved
-6.1% vs TC avg
Strong +19% interview lift
Without
With
+18.8%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
40 currently pending
Career history
1249
Total Applications
across all art units

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 1 and 4-18 are rejected under 35 U.S.C. 103 as being unpatentable over WO 2019/106642 and further in view of Hung et al. (US 2002/0002343). With reference to claim 1, WO 2019/106642 (hereinafter “Fabrikant”) discloses a liquid transfer device (abstract), comprising: an IV spike (102) configured to connect to an infusion liquid container (page 1, lines 5-6); a vial adaptor configured to mount onto a vial (page 10, lines 28-32); an IV port (106) configured to connect to an infusion set (figure 4); and a valve (118) movable between a first state and a second state as discussed on page 10, lines 25-35. Fabrikant describes a three rotation position stopcock arrangement that prevents all fluid communication in a first state and provides selective fluid communication in second and third states (page 11, lines 4-17) and anticipates 3 way flow communication as set forth on page 18, lines 33-35. The difference between Fabrikant and claim 1 is the explicit recitation that the valve is configured to provide fluid communication between a first IV spike lumen of the IV spike and the vial adaptor and fluid communication between a second IV spike lumen of the IV spike and the IV port in the second state. Hung et al. (hereinafter “Hung”) teaches an analogous dual lumen system that is configured to control fluid communication together and/or separately between multiple lumens as set forth in [0092]. It would have been obvious to one of ordinary skill in the art at the time of the invention to substitute the connector of Fabrikant with the connector as taught by Hung in order to ensure precise fluid control between desired components as taught by Hung in [0092].. Regarding claim 4, Fabrikant discloses a liquid transfer device wherein the valve comprises a first lumen configured to provide fluid communication between the first IV spike lumen and the vial adaptor, and a second lumen configured to provide fluid communication between the second IV spike lumen and the IV port as set forth on page 1, line 8 to page 2, line 4 through the incorporation of WO 2015/019343 and the recited steps. With reference to claims 5 and 7, Fabrikant discloses a liquid transfer device wherein the vial adaptor comprises a vial spike to puncture a vial stopper of the vial to provide fluid communication with the vial as set forth on page 9, lines 29-30. Regarding claim 6, Fabrikant discloses a liquid transfer device with a compactable vial adaptor wherein the vial adaptor comprises an outer vial adaptor body (111) and an inner vial adaptor body (109) configured to mount onto a vial, wherein the inner vial adaptor body is configured to slide within the outer vial adaptor body when the vial adaptor undergoes compaction from a non-compacted state to a compacted state as set forth on page 10, lines 27-35. As to claim 8, Fabrikant, through the incorporation of WO 2015/019343 in [0002], discloses a liquid transfer device further comprising a valve actuator movable between a first position and a second position, wherein the valve actuator is configured to move from the first position to the second position upon compaction of the vial adaptor as disclosed by WO 2015/019343. With respect to claims 9 and 15, see the rejection of claim 1. Additionally, Fabrikant discloses a liquid transfer device wherein the valve actuator is configured to drive the valve from the first state when the valve actuator is in the first position to the second state when the valve actuator is in a second position upon compaction of the vial adaptor as set forth on page 11, lines 1-17. As to claims 10 and 16, Fabrikant discloses a liquid transfer device wherein the valve comprises an angled face configured to engage with the valve actuator as shown in figures 6A-8A. As to claim 11, Fabrikant discloses a liquid transfer device further comprising a safety catch which is configured to prevent compaction of the vial adaptor in the non-compacted state as set forth on page 11, lines 18-20. Regarding claims 12-13, Fabrikant discloses a liquid transfer device further comprising a connector body having the IV spike, the vial adaptor and the IV port coupled thereto, wherein the valve is movable within the connector body between the first state and the second state and including a bore, a locking protrusion configured to function as claimed as set forth on pages 12-16. As to claim 14, see the rejection of claims 6 and 8. With reference to claim 17, see the rejection of claim 1. The valve is fully capable of performing the recited function. As to claim 18, Fabrikant discloses a liquid transfer device further comprising a valve cavity, wherein one of the valve or the valve cavity has a rail and another of the valve or the valve cavity has a groove receiving the rail as shown in figure 17. Response to Arguments Applicant’s arguments with respect to claims 1 and 4-18 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MICHELE M KIDWELL whose telephone number is (571)272-4935. The examiner can normally be reached Monday-Friday, 7AM-4PM EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Rebecca Eisenberg can be reached at 571-270-5879. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MICHELE KIDWELL/Primary Examiner, Art Unit 3781
Read full office action

Prosecution Timeline

Jan 11, 2024
Application Filed
Jun 03, 2026
Non-Final Rejection mailed — §103
Aug 07, 2026
Response Filed
Oct 21, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12778809
MUTLIPLE FLUID PATHWAY CONNECTOR WITH FOAM SUPPORTS
4y 3m to grant Granted Nov 03, 2026
Patent 12778816
WEARING ARTICLE
3y 5m to grant Granted Nov 03, 2026
Patent 12773354
Nursing Pad System
4y 7m to grant Granted Oct 27, 2026
Patent 12773357
ABSORBENT ARTICLES WITH ABSORBENT CHASSIS AND BELT ELASTIC ARRANGEMENTS AND FRANGIBLE PATHWAYS
3y 4m to grant Granted Oct 27, 2026
Patent 12766049
REUSABLE SWIM DIAPER
3y 2m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
64%
Grant Probability
83%
With Interview (+18.8%)
Moderate
PTA Risk
Based on 1195 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month